MedWatch

EU to help vaccine manufacturers expand production

The slow start to vaccinations in the EU owes to lack of factories, not lack of planning, says EU Commissioner.

Photo: SAMEER AL-DOUMY/AFP / AFP

EU is poised to assist pharmaceutical firms in expanding the production of vaccines against Covid-19 to avoid "bottlenecks", according to the EU's Health and Food Safety Commissioner Stella Kyriakides by way of the French news agency AFP.

Kyriakides explains that potential delays in introducing approved vaccines to society owe to a lack of production capacity, and not to the lack of EU planning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

In a world of options, Genmab's CEO chose partnerships

In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.

Further reading

Related articles

Latest news

See all jobs